Source:http://linkedlifedata.com/resource/pubmed/id/20203683
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0019004,
umls-concept:C0025344,
umls-concept:C0026565,
umls-concept:C0030705,
umls-concept:C0039155,
umls-concept:C0445456,
umls-concept:C0456603,
umls-concept:C0549193,
umls-concept:C0681842,
umls-concept:C0812388,
umls-concept:C1561960,
umls-concept:C1704788,
umls-concept:C1948053,
umls-concept:C2347804
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-5-5
|
pubmed:abstractText |
Impaired left ventricular systolic function is an important cause of mortality in hemodialysis patients. An increase in the ratio of pre-ejection period (PEP) to ejection time (ET) is associated with a decrease in left ventricular systolic function. Brachial PEP (bPEP) and brachial ET (bET) can be automatically determined from an ankle-brachial index (ABI)-form device. The aim of this study was to investigate whether bPEP/bET was a useful predictor for overall and cardiovascular mortality in hemodialysis patients. We enrolled 212 hemodialysis patients in one regional hospital. The bPEP and bET were measured using an ABI-form device. The mean follow-up period was 28.3+/-5.7 months. The relative mortality risk was analyzed by Cox-regression methods. Twenty-two deaths were recorded in 212 patients (10.4%). In a multivariate analysis, the bPEP/bET (hazard ratio [HR], 1.055; P=0.047) and serum creatinine level (P=0.029) were positively and negatively associated with overall mortality, respectively. In addition, increased bPEP/bET (HR, 1.080; P=0.017), increased fasting glucose (P=0.046) and decreased serum creatinine level (P=0.004) were independent predictors for cardiovascular mortality. Our findings show that bPEP/bET, a surrogate of left ventricular systolic function, is a useful predictor for overall and cardiovascular mortality in hemodialysis patients. Screening hemodialysis patients by means of bPEP/bET may help to identify a high-risk group for increased mortality.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1348-4214
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
492-8
|
pubmed:meshHeading |
pubmed-meshheading:20203683-Adult,
pubmed-meshheading:20203683-Aged,
pubmed-meshheading:20203683-Brachial Artery,
pubmed-meshheading:20203683-Chi-Square Distribution,
pubmed-meshheading:20203683-Creatinine,
pubmed-meshheading:20203683-Female,
pubmed-meshheading:20203683-Humans,
pubmed-meshheading:20203683-Kidney Failure, Chronic,
pubmed-meshheading:20203683-Male,
pubmed-meshheading:20203683-Middle Aged,
pubmed-meshheading:20203683-Multivariate Analysis,
pubmed-meshheading:20203683-Predictive Value of Tests,
pubmed-meshheading:20203683-Renal Dialysis,
pubmed-meshheading:20203683-Risk,
pubmed-meshheading:20203683-Risk Assessment,
pubmed-meshheading:20203683-Ventricular Dysfunction, Left
|
pubmed:year |
2010
|
pubmed:articleTitle |
A new systolic parameter defined as the ratio of brachial pre-ejection period to brachial ejection time predicts overall and cardiovascular mortality in hemodialysis patients.
|
pubmed:affiliation |
Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|